Press "Enter" to skip to content

New patent for Dow Pharm drug ONEXTON

0
Listen to this article
Subscribe
Voiced by Amazon Polly
Copyright © DrugPatentWatch. Originally published at New patent for Dow Pharm drug ONEXTON

Annual Drug Patent Expirations for ONEXTON
Annual Drug Patent Expirations for ONEXTON

Onexton is a drug marketed by Dow Pharm and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for ONEXTON.

This drug has seventeen patent family members in eleven countries.

The generic ingredient in ONEXTON is benzoyl peroxide; clindamycin phosphate. Three suppliers are listed for this compound. Additional details are available on the benzoyl peroxide; clindamycin phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Copyright © DrugPatentWatch. Originally published at New patent for Dow Pharm drug ONEXTON
Do NOT follow this link or you will be banned from the site!